Covance Not Cooling...
Health Care: Drugs
Aastrom Biosciences Inc. (ASTM: NASDAQ)
$0.57 -0.02 | -3.39%
05/17/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 2.76M | 2.71M | 2.40M | 2.40M | 2.56M | 2.56M | 2.57M |
| Shares Bought | 492,665 | 444,471 | 79,552 | 82,369 | 696,887 | 697,523 | 702,023 |
| Shares Sold | 234,899 | 234,768 | 184,254 | 196,254 | 3.31M | 3.30M | 3.29M |
Portfolios with ASTM
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- UserMark
- UserMy Portfolio As of 7/15/2012
- Userdonnieny7 Portfolio 1 Specu...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Cheap Biotech Stocks Tha...
- Usermrtimrx WatchList
- UserMy Folly
- Userbosw119
- Usergellis1360 Portfolio 1
Latest ASTM Headlines from TheStreet
- Aastrom Biosciences Reports First Quarter 2013 Financial Results 05.08.13 | 04:05 pm
- Aastrom To Host First Quarter 2013 Investor Call On May 8, 2013 05.03.13 | 04:05 pm
- Aastrom To Hold Annual Meeting Of Shareholders On May 2, 2013 04.25.13 | 04:04 pm
- Aastrom Biosciences Announces First Patients Treated In IxCELL-DCM Clinical Study Of Ixmyelocel-T 04.19.13 | 09:04 am
- Aastrom Biosciences To Present At Multiple Conferences In April 04.09.13 | 04:04 pm
- Aastrom Biosciences Announces First Patients Enrolled In IxCELL-DCM Phase 2b Clinical Trial Of Ixmyelocel-T 04.04.13 | 09:04 am
- Aastrom Biosciences Announces Strategic Change In Research And Development Programs To Focus On Dilated Cardiomyopathy And Other Rare Disease Indications 03.27.13 | 08:03 am
- Aastrom Biosciences Reports Fourth-Quarter And Year-End 2012 Financial Results 03.18.13 | 04:03 pm
- Aastrom To Host Fourth Quarter 2012 Investor Call On March 18, 2013 03.12.13 | 04:03 pm
- Aastrom Board Of Directors Names Dominick C. Colangelo President And Chief Executive Officer 03.06.13 | 04:03 pm
Press Releases for ASTM
Partner Headlines for ASTM
- Is Takeda Interested In Aastrom Bio? - Seeking Alpha 02.27.13 | 09:02 am
- Seven Innovative Biotechs That Could Soar by Year-End: George Zavoico - NASDAQ 09.13.12 | 05:09 pm
- Cell Therapy Outlook Starting To Match Clinical Results - Seeking Alpha 08.21.12 | 09:08 am
- Talisman Energy UPGRADED to Buy and 2 Analyst-Upgraded Shares to Notice - Wall St. Cheat Sheet 07.24.12 | 06:07 am
- Analysts Release These New Equity Ratings Monday - Wall St. Cheat Sheet 06.04.12 | 03:06 am
- Follow the Analyst Leader: New Stock Coverage to Watch - Wall St. Cheat Sheet 05.31.12 | 04:05 am
- Medgenics Moving In Record Time - Seeking Alpha 05.21.12 | 09:05 am
- Aastrom Biosciences Announces Initiation of Patient Enrollment in REVIVE Phase 3 Clinical Trial of Ixmyelocel-T - Benzinga 02.29.12 | 04:02 pm
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
- Aastrom Bio: Final RESTORE Data Looks Solid - Seeking Alpha 11.15.11 | 09:11 am
